Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    NISSHIN PHARMA INC

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Nisshin Pharma Inc.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    RDD
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    RDD
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2023-09-08

    NISSHIN PHARMA INC

    City : Ueda

    State :

    Country/Area : Japan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2023-09-08

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    RDD
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    RDD
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-12-18

    NISSHIN PHARMA INC

    City : Ueda

    State :

    Country/Area : Japan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-12-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    RDD
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    RDD
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-04-12

    NISSHIN PHARMA INC

    City : Ueda

    State :

    Country/Area : Japan

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-04-12

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Nisshin Pharma Inc and get a quotation

    Nisshin Pharma Inc is a supplier offers 7 products (APIs, Excipients or Intermediates).

    Find Icosapent Ethyl bulk with DMF, JDMF offered by Nisshin Pharma Inc

    Find Vitamin K1 bulk with JDMF offered by Nisshin Pharma Inc

    Find Alfacalcidol bulk with JDMF offered by Nisshin Pharma Inc

    Find Hydrochloric Acid bulk with JDMF offered by Nisshin Pharma Inc

    Find Tocoretinate bulk with JDMF offered by Nisshin Pharma Inc

    Find Ubidecarenone bulk with JDMF offered by Nisshin Pharma Inc

    Find Vitamin K2 bulk with JDMF offered by Nisshin Pharma Inc

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.